Although our bulk TCR-seq supports the first possibility for the source of tumor-reactive T cells induced by PD-L1 blockade, further work is required to identify the functional status–clonotype relationship of T cells using single-cell RNA-seq and TCR-seq. This evidence concerns the gene CD274 and neoplasm.